Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1Phase 1 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Neoplasm Metastasis 2Melanoma 2Breast Neoplasms 2Brain Neoplasms 2Thyroid Cancer, Papillary 1Solid Tumors 1Sarcoma 1Salivary Gland Neoplasms 1Rare Tumour 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Noonan Syndrome 6 1Neuroendocrine Tumors 1Neoplasms, Unknown Primary 1Neoplasms 1Lymphoma, Large-Cell, Anaplastic 1Locally Advanced Thyroid Gland Carcinoma 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Glioma 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Cholangiocarcinoma 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Lobular 1Advanced Unresectable or Metastatic Solid Malignancy 1

Interventions

Oxaliplatin 67Capecitabine 60Fluorouracil 58Bevacizumab 54Gemcitabine 51Paclitaxel 50Leucovorin 50Irinotecan 40Docetaxel 39Carboplatin 39Cisplatin 38pembrolizumab 37Nivolumab 37Cetuximab 35Sunitinib 25Trastuzumab 24Radiosurgery 24Radiotherapy 21Doxorubicin 21Cyclophosphamide 21Panitumumab 20Drug Therapy 19Pemetrexed 18Everolimus 18Sorafenib 17Interleukin-2 16Fulvestrant 16Albumin-Bound Paclitaxel 16atezolizumab 15Erlotinib Hydrochloride 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Neoplasm Metastasis × entrectinib × Clear all
NCT03994796 2026-04-13

Genetic Testing in Guiding Treatment for Patients With Brain Metastases

Alliance for Clinical Trials in Oncology

Phase 2 Active not recruiting
50 enrolled
CNS

Brain Neoplasms, Neoplasm Metastasis

NCT04817956 2024-02-29

IMPRESS-N

Oslo University Hospital

Phase 2 Recruiting
3,000 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡